Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target group represents a complex assembly of structural, enzymatic, and chemical entities that define the cellular microenvironment and its response to stress. The extracellular matrix (ECM) provides essential structural support, while the CD44 family of receptors facilitates cell-matrix communication, playing a pivotal role in cell migration and tumor metastasis (Source: UniProt P16070). Collagen-related hydroxylase enzymes, including prolyl and lysyl hydroxylases, are required for the proper folding and cross-linking of collagen fibers, and their overactivity is directly linked to the progression of fibrotic diseases (Source: PubMed PMID: 28245466). Reactive oxygen species (ROS) are highly reactive molecules that act as signaling intermediates but can cause extensive oxidative damage to cellular components when the antioxidant balance is disrupted (Source: PubChem). Therapeutic approaches targeting these elements include monoclonal antibodies against CD44 variants, small-molecule inhibitors of collagen-modifying enzymes, and antioxidant therapies designed to neutralize ROS (Source: NIH). Given the diversity of these components, they are often studied together in the context of the tumor microenvironment and chronic inflammatory conditions (Source: StatPearls).
Inhibition of CD44 receptor binding, inhibition of collagen hydroxylase activity, and scavenging of reactive oxygen species.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix structural components and CD44 family receptors; collagen-related hydroxylase enzymes and reactive oxygen species.